Twice-Weekly Outpatient Rehabilitation Intervention for Young Children With Spinal Muscular Atrophy Treated With Genetic-Based Therapies: Protocol for a Feasibility Study
BackgroundSpinal muscular atrophy (SMA) is a progressive neuromuscular disorder that causes muscle weakness and is the leading genetic cause of infant mortality worldwide. While no definitive cure exists, the approval of 3 genetic-based therapies in Canada since 2018 has led...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
JMIR Publications
2023-11-01
|
| Series: | JMIR Research Protocols |
| Online Access: | https://www.researchprotocols.org/2023/1/e46363 |
| _version_ | 1797641171258834944 |
|---|---|
| author | Christina Ippolito Lathushikka Canthiya Amanda Floreani Kathleen Luckhart Andrea Hoffman Laura McAdam |
| author_facet | Christina Ippolito Lathushikka Canthiya Amanda Floreani Kathleen Luckhart Andrea Hoffman Laura McAdam |
| author_sort | Christina Ippolito |
| collection | DOAJ |
| description |
BackgroundSpinal muscular atrophy (SMA) is a progressive neuromuscular disorder that causes muscle weakness and is the leading genetic cause of infant mortality worldwide. While no definitive cure exists, the approval of 3 genetic-based therapies in Canada since 2018 has led to significant improvements in muscle function for children with SMA. With that, there are no evidence-based rehabilitation interventions and minimal evidence on the combined effects of genetic-based therapies and rehabilitation.
ObjectiveThis protocol describes the methodology to assess the feasibility of a twice-weekly outpatient rehabilitation intervention focusing on gross and fine motor function to inform the methodology and sample size of a definitive clinical trial.
MethodsWe will conduct a single-center nonrandomized pilot and feasibility trial to explore an outpatient rehabilitation intervention for children aged 6 months to 3 years with SMA treated with genetic-based therapies. Participation in the study will occur over a 25-week period, with a baseline assessment visit followed by a 12-week intervention period and a 12-week nonintervention period. The rehabilitation intervention comprises weekly physical and occupational therapy for 11 weeks. Assessments will occur at baseline (week 0), end of intervention or early withdrawal (week 12), and follow-up (week 24). Predetermined feasibility indicators will evaluate study feasibility across process (recruitment rates, eligibility criteria, adherence rates, retention rates, questionnaire suitability, and acceptability), resource (time, implementation, and execution), management (materials and data), and scientific (safety, tolerability, and preliminary efficacy) domains.
ResultsThis project was funded in March 2022, and data will be collected between March 2023 and December 2023. Data analysis will occur between January 2024 and March 2024, with publication expected in the fall of 2024. The protocol for the feasibility trial will be considered successful if it meets the success criteria set out for the feasibility indicators. Indicators of specific interest include all process indicators, as well as time. Exploratory indicators will be reported. Pragmatically, the results of the feasibility trial will inform changes to the protocol and the start-up of a definitive multisite trial.
ConclusionsThis novel twice-weekly outpatient rehabilitation intervention will be the first step toward filling the need for an evidence-based rehabilitation intervention for children with SMA treated with genetic-based therapies. It is expected that consistent and intensive rehabilitation therapy will augment functional gains being observed in this population. In the future, a definitive trial will measure the efficacy of the intervention.
Trial RegistrationClinicalTrials.gov NCT05638750; https://clinicaltrials.gov/study/NCT05638750
International Registered Report Identifier (IRRID)DERR1-10.2196/46363 |
| first_indexed | 2024-03-11T13:41:43Z |
| format | Article |
| id | doaj.art-bc0aeae889fd49a196b74d5577c69d37 |
| institution | Directory Open Access Journal |
| issn | 1929-0748 |
| language | English |
| last_indexed | 2024-03-11T13:41:43Z |
| publishDate | 2023-11-01 |
| publisher | JMIR Publications |
| record_format | Article |
| series | JMIR Research Protocols |
| spelling | doaj.art-bc0aeae889fd49a196b74d5577c69d372023-11-02T12:30:34ZengJMIR PublicationsJMIR Research Protocols1929-07482023-11-0112e4636310.2196/46363Twice-Weekly Outpatient Rehabilitation Intervention for Young Children With Spinal Muscular Atrophy Treated With Genetic-Based Therapies: Protocol for a Feasibility StudyChristina Ippolitohttps://orcid.org/0000-0003-2217-7790Lathushikka Canthiyahttps://orcid.org/0000-0003-2312-5941Amanda Floreanihttps://orcid.org/0000-0002-5478-2357Kathleen Luckharthttps://orcid.org/0000-0001-6135-9656Andrea Hoffmanhttps://orcid.org/0009-0000-6616-2473Laura McAdamhttps://orcid.org/0000-0002-4650-7232 BackgroundSpinal muscular atrophy (SMA) is a progressive neuromuscular disorder that causes muscle weakness and is the leading genetic cause of infant mortality worldwide. While no definitive cure exists, the approval of 3 genetic-based therapies in Canada since 2018 has led to significant improvements in muscle function for children with SMA. With that, there are no evidence-based rehabilitation interventions and minimal evidence on the combined effects of genetic-based therapies and rehabilitation. ObjectiveThis protocol describes the methodology to assess the feasibility of a twice-weekly outpatient rehabilitation intervention focusing on gross and fine motor function to inform the methodology and sample size of a definitive clinical trial. MethodsWe will conduct a single-center nonrandomized pilot and feasibility trial to explore an outpatient rehabilitation intervention for children aged 6 months to 3 years with SMA treated with genetic-based therapies. Participation in the study will occur over a 25-week period, with a baseline assessment visit followed by a 12-week intervention period and a 12-week nonintervention period. The rehabilitation intervention comprises weekly physical and occupational therapy for 11 weeks. Assessments will occur at baseline (week 0), end of intervention or early withdrawal (week 12), and follow-up (week 24). Predetermined feasibility indicators will evaluate study feasibility across process (recruitment rates, eligibility criteria, adherence rates, retention rates, questionnaire suitability, and acceptability), resource (time, implementation, and execution), management (materials and data), and scientific (safety, tolerability, and preliminary efficacy) domains. ResultsThis project was funded in March 2022, and data will be collected between March 2023 and December 2023. Data analysis will occur between January 2024 and March 2024, with publication expected in the fall of 2024. The protocol for the feasibility trial will be considered successful if it meets the success criteria set out for the feasibility indicators. Indicators of specific interest include all process indicators, as well as time. Exploratory indicators will be reported. Pragmatically, the results of the feasibility trial will inform changes to the protocol and the start-up of a definitive multisite trial. ConclusionsThis novel twice-weekly outpatient rehabilitation intervention will be the first step toward filling the need for an evidence-based rehabilitation intervention for children with SMA treated with genetic-based therapies. It is expected that consistent and intensive rehabilitation therapy will augment functional gains being observed in this population. In the future, a definitive trial will measure the efficacy of the intervention. Trial RegistrationClinicalTrials.gov NCT05638750; https://clinicaltrials.gov/study/NCT05638750 International Registered Report Identifier (IRRID)DERR1-10.2196/46363https://www.researchprotocols.org/2023/1/e46363 |
| spellingShingle | Christina Ippolito Lathushikka Canthiya Amanda Floreani Kathleen Luckhart Andrea Hoffman Laura McAdam Twice-Weekly Outpatient Rehabilitation Intervention for Young Children With Spinal Muscular Atrophy Treated With Genetic-Based Therapies: Protocol for a Feasibility Study JMIR Research Protocols |
| title | Twice-Weekly Outpatient Rehabilitation Intervention for Young Children With Spinal Muscular Atrophy Treated With Genetic-Based Therapies: Protocol for a Feasibility Study |
| title_full | Twice-Weekly Outpatient Rehabilitation Intervention for Young Children With Spinal Muscular Atrophy Treated With Genetic-Based Therapies: Protocol for a Feasibility Study |
| title_fullStr | Twice-Weekly Outpatient Rehabilitation Intervention for Young Children With Spinal Muscular Atrophy Treated With Genetic-Based Therapies: Protocol for a Feasibility Study |
| title_full_unstemmed | Twice-Weekly Outpatient Rehabilitation Intervention for Young Children With Spinal Muscular Atrophy Treated With Genetic-Based Therapies: Protocol for a Feasibility Study |
| title_short | Twice-Weekly Outpatient Rehabilitation Intervention for Young Children With Spinal Muscular Atrophy Treated With Genetic-Based Therapies: Protocol for a Feasibility Study |
| title_sort | twice weekly outpatient rehabilitation intervention for young children with spinal muscular atrophy treated with genetic based therapies protocol for a feasibility study |
| url | https://www.researchprotocols.org/2023/1/e46363 |
| work_keys_str_mv | AT christinaippolito twiceweeklyoutpatientrehabilitationinterventionforyoungchildrenwithspinalmuscularatrophytreatedwithgeneticbasedtherapiesprotocolforafeasibilitystudy AT lathushikkacanthiya twiceweeklyoutpatientrehabilitationinterventionforyoungchildrenwithspinalmuscularatrophytreatedwithgeneticbasedtherapiesprotocolforafeasibilitystudy AT amandafloreani twiceweeklyoutpatientrehabilitationinterventionforyoungchildrenwithspinalmuscularatrophytreatedwithgeneticbasedtherapiesprotocolforafeasibilitystudy AT kathleenluckhart twiceweeklyoutpatientrehabilitationinterventionforyoungchildrenwithspinalmuscularatrophytreatedwithgeneticbasedtherapiesprotocolforafeasibilitystudy AT andreahoffman twiceweeklyoutpatientrehabilitationinterventionforyoungchildrenwithspinalmuscularatrophytreatedwithgeneticbasedtherapiesprotocolforafeasibilitystudy AT lauramcadam twiceweeklyoutpatientrehabilitationinterventionforyoungchildrenwithspinalmuscularatrophytreatedwithgeneticbasedtherapiesprotocolforafeasibilitystudy |